Category: testosterone for women
9 News: World-first trial of testosterone to help treat early menopause.
IMS – 18th World Congress On Menopause – Available on Demand
Available on Demand The conference will also be available in streaming for those who are unable to travel and all the sessions will be… Continue Reading →
Find A Doctor Who Knows Menopause
Find an AMS doctor To help you find a doctor who is right for you, the AMS has assembled this search feature of AMS… Continue Reading →
World Menopause Day – 18th October 2022 with BMS
The British Menopause Society are continuing the conversation around Menopause. The menopause has gone mainstream and after the deafening silence surrounding it for so… Continue Reading →
IMS – 18th World Congress On Menopause – Will we see you in Lisbon?
Available on Demand The conference will also be available in streaming for those who are unable to travel and all the sessions will be… Continue Reading →
AndroFeme 1 included on ARTG for hypoactive sexual desire dysfunction in postmenopausal women
Lawley Pharmaceuticals’ female-specific hormone cream, AndroFeme® 1, has been registered on the Australian Register of Therapeutic Goods (ARTG) for the treatment of postmenopausal women… Continue Reading →
AndroFeme 1 licensed for hypoactive sexual desire dysfunction in postmenopausal women
Lawley Pharmaceuticals has obtained approval for registration of AndroFeme® 1 in the Australian Register of Therapeutic Goods (ARTG) for the treatment of postmenopausal women… Continue Reading →
Tanner Pharma Group and Lawley Pharmaceuticals Initiate Global Named Patient Program for AndroFeme® 1
Friday 12th June 2020 Perth, Australia and Charlotte, USA – Lawley Pharmaceuticals and Tanner Pharma Group announced today that they have initiated a global… Continue Reading →
Tanner Pharma Group and Lawley Pharmaceuticals Initiate Global Named Patient Program for AndroFeme® 1
Friday 12th June 2020 Perth, Australia and Charlotte, USA – Lawley Pharmaceuticals and Tanner Pharma Group announced today that they have initiated a global… Continue Reading →
TGA accepts AndroFeme 1 for evaluation in postmenopausal women with Hypoactive Sexual Desire Dysfunction.
TGA accepts AndroFeme 1 for evaluation in postmenopausal women with HSDD. Perth, Western Australia; Dec. 05, 2019 — Lawley Pharmaceuticals today announced AndroFeme 1,… Continue Reading →